- Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 28 May 2014
-
Current Status:
Answered by Alex Neil on 11 June 2014
To ask the Scottish Government, in light of its missing the 1 May 2014 introduction date, when it will introduce the new Patient and Clinician Engagement approval system.
Answer
Patient and Clinician Engagement now forms part of the Scottish Medicines Consortium (SMC) evaluation process. Submissions from pharmaceutical companies received by SMC after noon on 7 April 2014 are eligible for this new approach, in line with what was set out in the Task and Finish Group report provided to me and published by the Health and Sport Committee. The first decisions from this new process are expected in autumn 2014.
- Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 04 June 2014
-
Current Status:
Answered by Alex Neil on 11 June 2014
To ask the Scottish Government when it last met the chief executive of NHS Greater Glasgow and Clyde and what issues were discussed.
Answer
Both Ministers and Government officials regularly meet representatives of NHS Greater Glasgow and Clyde to discuss matters of importance to local people.
- Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 04 June 2014
-
Current Status:
Answered by Michael Matheson on 10 June 2014
To ask the Scottish Government what weight is given to cognitive behavioural therapy in the provision of mental health services.
Answer
The Scottish Government is committed to creating a well-functioning mental health system, where all therapeutic interventions are based around the needs of the individual, and recognises the important role cognitive behavioural therapy (CBT) plays within this.
NHS boards are working towards the HEAT target, ‘Deliver faster access to mental health services by delivering 18 weeks referral to treatment for Psychological therapies from December 2014’. CBT is one of the key psychological therapies delivered through this target.
We have published The Matrix: a Guide to Delivering Evidence-based Psychological Therapies in Scotland on what treatments are effective for which conditions. There is an evidence base to show that CBT is effective in the treatment of a range of conditions, including anxiety disorder, depression, panic disorder, obsessive compulsive disorder, borderline personality disorder, eating disorders, and the management of chronic pain.
- Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 28 May 2014
-
Current Status:
Answered by Alex Neil on 4 June 2014
To ask the Scottish Government what its position is regarding concerns raised by the scientific community that the recent amendments passed at the European Parliament to Articles 81 and 83 of the European Data Protection Regulation will harm the opportunities and benefits available as a result of Scotland’s health records data.
Answer
Data protection is a reserved area and the Ministry of Justice has made representations on behalf of all parts of the UK. The Scottish Government takes the view that it is not yet clear whether the conditions and safeguards set out in the amended Articles of Data Protection Regulation will have negative implications on research given that NHSScotland already has robust scrutiny and security controls in regard to requests to use patient-originated data for research. Article 83 (b) states that such processing must comply with all other relevant legislation, in each member state. As health is a devolved area, the Scottish Government will consider whether any statute or instrument through the Scottish Parliament, would assist in making clearer how health records are to be used by public bodies for research which directly benefits NHSScotland.
- Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 28 May 2014
-
Current Status:
Taken in the Chamber on 4 June 2014
To ask the Scottish Government whether it considers that the licensing of air weapons is a proportionate measure, given that offences involving such weapons have fallen by 75% since 2006-07.
Answer
Taken in the Chamber on 4 June 2014
- Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 30 April 2014
-
Current Status:
Answered by Alex Neil on 15 May 2014
To ask the Scottish Government, further to the answer to question S4W-20040 by Alex Neil on 17 March 2014, whether it will provide a breakdown by medicine of the £21.7 million Rare Conditions Medicines Fund expenditure.
Answer
The Scottish Government has no plans to publish expenditure on individual medicines.
- Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 30 April 2014
-
Current Status:
Answered by Alex Neil on 15 May 2014
To ask the Scottish Government when guidance will be issued to NHS boards to update the current Guidance to Further Strengthen the Safe and Effective Use of New Medicines across the NHS in Scotland, as issued in Chief Medical Officer's letter CMO (2012) 1, and associated guidance, including the timescale and implementation of Scottish Medicines Consortium advice at a local level.
Answer
The Scottish Government is reviewing the existing guidance. It is planned that further advice on expectations of the role of Area and Drug Therapeutic Committees will be issued later in 2014.
- Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 14 May 2014
-
Current Status:
Taken in the Chamber on 21 May 2014
To ask the Scottish Government whether it will develop appropriate outcome-based measures to assess the long-term benefits of modern apprenticeships, as recommended by Audit Scotland.
Answer
Taken in the Chamber on 21 May 2014
- Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 22 April 2014
-
Current Status:
Answered by Michael Matheson on 6 May 2014
To ask the Scottish Government what its response is to the recent Cochrane Collaboration report on the effectiveness of the antiviral drugs, Tamiflu and Relenza.
Answer
In collaboration with colleagues across the UK, we will consider all new relevant scientific evidence on the effectiveness of Tamiflu and Relenza. This will include the Cochrane Collaboration reviews published on 9 April 2014, which considered data from the initial trials of Tamiflu and Relenza, dating back to the late 1990s. It will also include evidence from other studies carried out since the medicines were licensed, which support the view that they can reduce severe outcomes such as intensive care admission or death. The results of this review will inform our next steps.
- Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 22 April 2014
-
Current Status:
Answered by Alex Neil on 30 April 2014
To ask the Scottish Government, further to the answer to question S4W-19996 by Alex Neil on 13 March 2014, what action NHS boards have taken to implement the recommendations set out in Neonatal Care in Scotland: A Quality Framework.
Answer
The new local delivery plan format, focusing on the 12 priority areas for action in the Route map to the 2020 Vision for Health and Social Care, gives NHS boards the opportunity to set out the action they are taking to implement Neonatal Care in Scotland: A Quality Framework. We continue to support the focus on performance across NHSScotland through the annual process of agreeing NHS board local delivery plans with improved monitoring and assessment of outcomes.
Considerable progress has already been made, with the vast majority of statements in Neonatal care in Scotland: A Quality Framework already being met. All neonatal units are working together with their NHS boards and neonatal managed clinical networks to achieve full implementation of the framework. The Scottish Government has been clear that the framework will need to be implemented over a 5 to 10 year timescale to allow boards and regions flexibility to suit the needs of their local population in combination with staffing and resources.